These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients. McCollam S, Lewis JS, Bubalo J, Diaz A. Antimicrob Agents Chemother; 2022 Nov 15; 66(11):e0083322. PubMed ID: 36214573 [Abstract] [Full Text] [Related]
10. Safety and Effectiveness of Intravenous Pentamidine for Prophylaxis of Pneumocystis jirovecii Pneumonia in Pediatric Hematology/Oncology Patients. Solodokin LJ, Klejmont LM, Scipione MR, Dubrovskaya Y, Lighter-Fisher J, Papadopoulos J. J Pediatr Hematol Oncol; 2016 Aug 15; 38(6):e180-5. PubMed ID: 27164533 [Abstract] [Full Text] [Related]
11. Safe and Effective Prophylaxis with Bimonthly Intravenous Pentamidine in the Pediatric Hematopoietic Stem Cell Transplant Population. Levy ER, Musick L, Zinter MS, Lang T, Cowan MJ, Weintrub PS, Dvorak CC. Pediatr Infect Dis J; 2016 Feb 15; 35(2):135-41. PubMed ID: 26418240 [Abstract] [Full Text] [Related]
12. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T. Bone Marrow Transplant; 1999 Oct 15; 24(8):897-902. PubMed ID: 10516703 [Abstract] [Full Text] [Related]
13. Efficacy and tolerability of intravenous pentamidine isethionate for Pneumocystis jiroveci prophylaxis in a pediatric oncology population. Orgel E, Rushing T. Pediatr Infect Dis J; 2014 Mar 15; 33(3):319-21. PubMed ID: 24030353 [Abstract] [Full Text] [Related]
15. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era. Evernden C, Dowhan M, Dabas R, Chaudhry A, Kalra A, Dharmani-Khan P, Gregson D, Johnson A, Jupp J, Jimenez-Zepeda V, Jamani K, Duggan P, Tay J, Khan F, Daly A, Storek J. Cytotherapy; 2020 Jan 15; 22(1):27-34. PubMed ID: 31889628 [Abstract] [Full Text] [Related]
18. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia. Warnock AC, Rimland D. Pharmacotherapy; 1996 Jan 15; 16(6):1030-8. PubMed ID: 8947975 [Abstract] [Full Text] [Related]
19. Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients. Kim SY, Dabb AA, Glenn DJ, Snyder KM, Chuk MK, Loeb DM. Pediatr Blood Cancer; 2008 Apr 15; 50(4):779-83. PubMed ID: 17635000 [Abstract] [Full Text] [Related]
20. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. Carr A, Tindall B, Penny R, Cooper DA. AIDS; 1992 Feb 15; 6(2):165-71. PubMed ID: 1558714 [Abstract] [Full Text] [Related] Page: [Next] [New Search]